Reinforcing Therapist Performance (RTP)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Chestnut Health Systems
ClinicalTrials.gov Identifier:
NCT01016704
First received: November 18, 2009
Last updated: July 26, 2011
Last verified: July 2011
  Purpose

The specific aims of the proposed study are to evaluate the effectiveness and cost-effectiveness of providing monetary incentives to therapists as a method to improve implementation of evidence-based treatments.


Condition Intervention
Substance Use
Behavioral: Incentive

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Reinforcing Therapist Performance

Further study details as provided by Chestnut Health Systems:

Primary Outcome Measures:
  • Target A-CRA [ Time Frame: 14 weeks post intake ] [ Designated as safety issue: No ]
    Based on a review of recordings of actual client sessions is an indicator of whether or not clients received 10 or more of 12 specified treatment procedures within no less than seven treatment sessions.

  • A-CRA Competence [ Time Frame: Monthly ] [ Designated as safety issue: No ]
    Based on review of a randomly selected session recording is an indicator of whether or not participants delivered at least one treatment procedure at or above the level of competence required as part of the certification process.


Secondary Outcome Measures:
  • Percent of days abstinent [ Time Frame: 6 months post-intake ] [ Designated as safety issue: No ]
    Based on client self report is the percentage of days during the past 90 days that clients reported not using any alcohol or other drugs.

  • Pay-for-performance Cost-Effectiveness [ Time Frame: First six months of study ] [ Designated as safety issue: No ]
    The cost per unit of Target A-CRA, A-CRA Competene, and Percentage of Days Abstient in the experimental condition relative to the control condition.


Enrollment: 105
Study Start Date: November 2008
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Experimental: Incentive Behavioral: Incentive
Participants assigned to the experimental condition are reinforced via monetary incentives for demonstrating superior delivery of an evidence treatment to clients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must work at one of the participating demonstration sites funded by the Center for Substance Abuse Treatment to deliver the Adolescent Community Reinforcement Approach and/or Assertive Continuing Care.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01016704

Locations
United States, Illinois
Lighthouse Institute, Chestnut Health Systems
Normal, Illinois, United States, 61761
Sponsors and Collaborators
Chestnut Health Systems
Investigators
Principal Investigator: Bryan R Garner, Ph.D. Chestnut Health Systems
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Bryan R. Garner, Chestnut Health Systems
ClinicalTrials.gov Identifier: NCT01016704     History of Changes
Other Study ID Numbers: RTP-1, 1R01AA017625-01
Study First Received: November 18, 2009
Last Updated: July 26, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 23, 2014